REVERSE-ENGINEERING NATURE
IMPROVING HEALTH OUTCOMES IN INNOVATIVE WAYS BASED ON NATURE’S WISDOM
BUSINESS
MODEL


Impact Biomedical drives mission-oriented research and development that advances drug discovery and development for the prevention, inhibition, and treatment of neurological, oncology and immuno-related diseases. Other exciting technologies include breakthrough alternative sugar in the aim to combat diabetes and Functional Fragrances Formulation (3F) for industrial and medical application, amongst others. The first product in 3F’s suite of functional fragrances is 3F Mosquito which is made up of specialised oils sourced from botanicals that mosquitoes avoid. The business model of Impact Biomedical revolves mainly around two methodologies – Licensing and Sales Distribution.
Licensing
Impact Biomedical develop valuable and unique patented technologies which could be licensed to pharmaceutical companies and venture capitalists in exchange for an agreed payment (fee or royalty). This interest will rise as the validating data becomes available.
Sales Distribution
On the other hand, Impact Biomedical has sister companies that have in place distribution networks on a global basis. Impact Biomedical will engage in private labelling to go into production of products for sales generation. We plan to expand our geographical presence globally and intend to launch more products to add on to the flagship product range.

FROM JUST 5 OUT OF 35 PREVIOUSLY RESTRUCTURED COMPANIES
APPROX. CURRENT MARKET CAP OVER
USD 19.9 BILLION
AND GROWING
BRINGING IN PROFITS OF OVER
USD 1 BILLION
PER ANNUM

Game Changer | Unicorn Maker | Financial Architect | Restructuring Expert
ZH International Limited
Formerly Known as Heng Fai Enterprises
Hong Kong Stock Exchange Listed
Restructured from Bankruptcy
Global Medical REIT
Hong Kong Stock Exchange Listed
Founded and Funded from Ground Zero
Singhaiyi Ltd
Formerly Known as SingXpress Land
Singapore Exchange Listed
Restructured from Bankruptcy
CHAN HENG FAI
EXECUTIVE CHAIRMAN
DIRECTORS, OFFICERS & ADVISORS
Chan Heng Fai
John 'JT' Thatch
William Harrison Lyerly, JR.
Daryl Thompson
Christina Glendening
Moe Chan

Ronald Wei
Frank D Heuszel
Scott Truesdell
Danny Lim
Michael Gershon
Jason Grady
Dr. Roscoe M. Moore
Robert Trapp
Products in the Pipeline

3F (Functional Fragrance Formulation) is a unique formulation of specialized ingredients (e.g. terpenes) from botanical sources with demonstrated effect as an insect repellent and an antimicrobial.
3F Mosquito Repellent
3F repellent contains botanical ingredients that mosquitos avoid. These ingredients are scientifically proven* to affect the mosquito’s receptors, essentially making the insect blind to a human’s presence. This can be utilized as a stand-alone repellent or as an additive in detergents, lotions, shampoo, and
other substances to provide mosquito protection.
3F Antimicrobial
3F antimicrobial contains botanical ingredients known to kill viruses. These ingredients are scientifically proven* to inhibit viral replication. This can be utilized as a stand-alone antimicrobial or as an additive in detergents, lotions, shampoo, fabrics, and other substances.
*Source: Company Data on File

Equivir/Nemovir technology is a novel blend of FDA Generally Recognized as Safe (GRAS) eligible polyphenols (e.g. Myricetin, Hesperetin, Piperine) which have demonstrated antiviral effects with
additional potential application as health supplements or medication. Polyphenols are sourced from fruits, vegetables, and other natural substances.
Myricetin is a member of the flavonoid class of polyphenolic compounds with antioxidant properties.
Hesperitin is a flavanone and Piperine is an alkaloid, commonly found in black pepper.

LineBacker is a platform of small molecule X-bonded polyphenols. X-bonding is a molecular tuning
technique that modifies a natural compound to induce potency, efficacy, bioavailability, and
trans-membrane permeability while maintaining safety, toxicity, and tolerability.
Natural polyphenols have demonstrated strong potential in treating and preventing a range of diseases
by inhibiting TNF- and indication specific causes (e.g. neurology, anti-inflammatory, oncology).
Two novel discrete LineBacker molecules have been synthesized and characterized including
in vitro testing.
LAETOSE
Laetose technology is derived from a unique combination of sugar and inositol, which demonstrates the ability to inhibit the inflammatory and metabolic response of sugar alone.
Use of Laetose in a daily diet, compared to sugar, could result in 30% lower sugar consumption and lower glycemic index/load*
*Source: Company data on file
Reports: Finance Yahoo | Confectionery News | Nutrition Insight
FUTURE PROJECTS
Unveiling Soon
MEDIA
Videos
Press Release
Title
Date
CONTACT
US
OUR ADDRESS
United States
Hampden Square 4800 Montgomery Lane, Suite 210
(1) 301 971 3955T / (1) 301 971 3940
Singapore
7 Temasek Boulevard #29-01B Suntec Tower One Singapore 038987
(65) 6333 9181
Hong Kong
7/Floor, Skyway Centre, 23 Queen’s Road West Sheung Wan, Hong Kong
(852) 2711 1808